Loading
Latest filing published 19 Feb 2025 for Arbutus Biopharma Corporation.
No signal scores available.
One trade, one date: on 19 February 2025, Karen Sims disclosed a share grant in Arbutus Biopharma Corporation. No broader history exists yet. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.